相关实验视频
Updated: Jul 5, 2025

08:23
CIRCLE-Seq for Interrogation of Off-Target Gene Editing
Published on: November 1, 2024
658
临床医生需要知道的基因组编辑:免疫的先天性错误的状态和机会
Anne C A Mudde1, Caroline Y Kuo2, Donald B Kohn3
1UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
The journal of allergy and clinical immunology. In practice
|January 21, 2024
概括
基因编辑为遗传疾病提供了一种新的基因治疗方法. 这项临床前研究探讨了利用造血干细胞治疗免疫系统的先天性错误的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
- 生物技术是生物技术.
背景情况:
- 基因编辑在过去二十年中取得了显著的进步,提供了新的治疗途径.
- 免疫的先天性错误是基因疾病,是基因治疗的主要候选人.
- 自主造血干细胞基因编辑是治疗这些疾病的有希望的策略.
研究的目的:
- 提供当前关于基因编辑用于免疫的先天性错误的临床前研究的概述.
- 突出这些疾病相关的基因编辑技术的最新进展.
- 评估基因编辑用于免疫疾病的临床应用的进展情况.
主要方法:
- 对调查基因编辑用于免疫的先天性错误的临床前研究的审查.
- 分析新兴的基因编辑技术及其在造血干细胞中的应用.
- 对临床转化研究进展的评估.
主要成果:
- 基因编辑技术正在成熟,在免疫的各种先天性错误中越来越多的应用.
- 研究仍处于临床前阶段,迄今为止还没有启动临床试验.
- 在改进基因编辑技术以实现潜在的治疗用途方面取得了重大进展.
结论:
- 基因编辑是一种有前途的新型基因疗法,用于免疫系统的先天性错误.
- 虽然仍处于临床前阶段,但进展表明向临床益处迈进.
- 进一步的研究和开发对于将基因编辑策略转化为有效的治疗方法至关重要.
相关概念视频
CRISPR
51.1K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
51.1K
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K
Homologous Recombination
50.6K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.6K

